NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 225 filers reported holding NOVAVAX INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $77,106 | -10.2% | 10,650 | -7.9% | 0.00% | – |
| Q2 2023 | $85,891 | +74.8% | 11,560 | +63.0% | 0.00% | – |
| Q1 2023 | $49,148 | -1.7% | 7,092 | +45.8% | 0.00% | – |
| Q4 2022 | $49,991 | -23.1% | 4,863 | +36.4% | 0.00% | – |
| Q3 2022 | $65,000 | -58.6% | 3,565 | +16.5% | 0.00% | – |
| Q2 2022 | $157,000 | -96.6% | 3,059 | -95.2% | 0.00% | – |
| Q1 2022 | $4,674,000 | -83.5% | 63,469 | -68.0% | 0.00% | -100.0% |
| Q4 2021 | $28,363,000 | -90.6% | 198,245 | -86.4% | 0.00% | -91.7% |
| Q3 2021 | $303,068,000 | -70.8% | 1,461,909 | -70.1% | 0.02% | -70.4% |
| Q2 2021 | $1,037,178,000 | +19.4% | 4,885,203 | +2.0% | 0.08% | +9.5% |
| Q1 2021 | $868,639,000 | +345.0% | 4,790,910 | +173.7% | 0.07% | +335.3% |
| Q4 2020 | $195,210,000 | +67.5% | 1,750,608 | +62.7% | 0.02% | +41.7% |
| Q3 2020 | $116,577,000 | +75599.4% | 1,075,933 | +58121.5% | 0.01% | – |
| Q2 2020 | $154,000 | – | 1,848 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,559,918 | $543,496,000 | 8.72% |
| Foresite Capital Management I, LLC | 66,810 | $14,184,000 | 8.55% |
| Samsara BioCapital, LLC | 198,600 | $42,165,000 | 5.20% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 330,541 | $70,177,000 | 4.54% |
| Foresite Capital Management II, LLC | 67,373 | $14,304,000 | 3.85% |
| Rock Springs Capital Management LP | 455,000 | $96,601,000 | 1.91% |
| DELTEC ASSET MANAGEMENT LLC | 56,320 | $11,957,000 | 1.65% |
| Parametrica Management Ltd | 10,200 | $2,166,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 88,450 | $18,779,000 | 1.52% |
| TSP Capital Management Group, LLC | 18,525 | $3,933,000 | 1.29% |